There is still so much to know about medical cannabis and how it can help multiple sclerosis patients.
In states that have legalized medical cannabis, multiple sclerosis is one of the common qualifying conditions for which a patient could obtain a license to use the drug. But even if that is the case, scientific studies and clinical trials are still limited. There is a lack of scientific evidence to support that cannabis can help in the treatment of the condition and its symptoms.
Because of this, the Multiple Sclerosis Society of Canada is investing C$1.5 million on research that is focused on the effects of cannabis on MS patients. The MS Society of Canada is partnering with the Canadian Institutes of Health Research to provide the research funding.
According to Dr. Pamela Valentine, the president and CEO of the MS Society of Canada, they have a mandate to provide information based on evidence. She said that the society is pleased to invest in this funding opportunity for Canadian MS research, which is the first of its kind.
Valentine explained that cannabis is relatively still an unknown substance when you look at it from an evidence-based perspective. This is why investing in cannabis research is an important first step in determining the drug’s efficacy and applicability where MS is concerned.
This $1.5-million investment is going to span more than five years to help accelerate research on cannabis health. Applications are being accepted for funding into health and clinical services, as well as into policy research approaches.
Announcement of this research opportunity is a part of what the organizations described as the Integrated Cannabis Research Strategy.
This strategy includes partnering with a number of organizations, including the Institute of Circulatory and Respiratory Health, the Institute of Cancer Research, the Institute of Human Development and Child and Youth Health, the Institute of Musculoskeletal Health and Arthritis, the Institute of Indigenous Peoples’ Health, and the Institute of Neurosciences, Mental Health, and Addiction. Also included are the Arthritis Society, the Mental Health Commission of Canada, the Canadian Cancer Society, and the MS Society.